Succesful treatment of severe pouchitis with rebamipide refractory to antibiotics and corticosteroids: A case report

World Journal of Gastroenterology

Volumn 12, Issue 4, 2006, Pages 656-658

  Miyata, Mitsuki ^a   Konagaya, Toshihiro ^a   Kakumu, Shiniti ^a   Mori, Takeshi ^a  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Epithelial cells; Ileo anal pouch; Rebamipide enema; Refractory pouchitis

Indexed keywords

ANTIBIOTIC AGENT; BETAMETHASONE; CORTICOSTEROID; ENEMA; HEMOGLOBIN; METRONIDAZOLE; REBAMIPIDE; ALANINE; ANTIINFECTIVE AGENT; DRUG DERIVATIVE; QUINOLONE DERIVATIVE;

ABDOMINAL PAIN; ABSENCE OF SIDE EFFECTS; ADULT; ANAL COMPLAINT; ANGIOGENESIS; ARTICLE; CASE REPORT; CELL REGENERATION; DEFECATION HABIT; DIARRHEA; DISEASE SEVERITY; DRUG MECHANISM; EPITHELIUM CELL; FECES LEVEL; FOLLOW UP; HEALING; HUMAN; ILEITIS; INFLAMMATION; INTESTINAL BLEEDING; INTESTINE ENDOSCOPY; INTESTINE MUCOSA; INTESTINE ULCER; MALE; MUCUS SECRETION; PAIN; REMISSION; TREATMENT FAILURE;

ADRENAL CORTEX HORMONES; ADULT; ALANINE; ANTI-BACTERIAL AGENTS; HUMANS; MALE; METRONIDAZOLE; POUCHITIS; QUINOLONES;

EID: 33644894745     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i4.656     Document Type: Article

References (13)

1. Hanauer SB. Medical therapy for ulcerative colitis 2004. Gastroenterology 2004; 126: 1582-159
2. Braveman JM, Schoetz DJ Jr, Marcello PW, Roberts PL, Coller JA, Murray JJ, Rusin LC. The fate of the ileal pouch in patients developing Crohn's disease. Dis Colon Rectum 2004; 47: 1613-1619
3. Kuisma J, Jarvinen H, Kahri A, Farkkila M. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004; 39: 544-548
4. Mahadevan U, Sandborn WJ. Diagnosis and management of pouchitis. Gastroenterology 2003; 124: 1636-1650
5. Kock NG, Darle N, Hulten L, Kewenter J, Myrvold H, Philipson B. Ileostomy. Curr Probl Surg 1977; 14: 1-52
6. West AB, Losada M. The pathology of diverticulosis coli. J Clin Gastroenterol 2004; 38: S11-16
7. McLeod RS, Taylor DW, Cohen Z, Cullen JB. Single-patient randomised clinical trial. Use in determining optimum treatment for patient with inflammation of Kock continent ileostomy reservoir. Lancet 1986; 1: 726-728
8. Madden MV, McIntyre AS, Nicholls RJ. Double-blind crossover trial of metronidazole versus placebo in chronic unremitting pouchitis. Dig Dis Sci 1994; 39: 1193-1196
9. Gionchetti P, Morselli C, Rizzello F, Romagnoli R, Campieri M, Poggioli G, Laureti S, Ugolini F, Pierangeli F. Management of pouch dysfunction or pouchitis with an ileoanal pouch. Best Pract Res Clin Gastroenterol 2004; 18: 993-1006
10. Tarnawski A, Arakawa T, Kobayashi K. Rebamipide treatment activates epidermal growth factor and its receptor expression in normal and ulcerated gastric mucosa in rats: one mechanism for its ulcer healing action? Dig Dis Sci 1998; 43: 90S-98S
11. Cleary RK. Clostridium difficile-associated diarrhea and colitis: clinical manifestations, diagnosis, and treatment. Dis Colon Rectum 1998; 41: 1435-1449
12. Arakawa T, Watanabe T, Fukuda T, Yamasaki K, Kobayashi K. Rebamipide, novel prostaglandin-inducer accelerates healing and reduces relapse of acetic acid-induced rat gastric ulcer. Comparison with cimetidine. Dig Dis Sci 1995; 40: 2469-2472
13. Tarnawski AS, Chai J, Pai R, Chiou SK. Rebamipide activates genes encoding angiogenic growth factors and Cox2 and stimulates angiogenesis: a key to its ulcer healing action? Dig Dis Sci 2004; 49: 202-209